Benzoxiquine

This classification denotes an anti-infective agent with the molecular formula C16H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GRE0P19C3Z, chemically known as 8-quinolinol, benzoate (ester) but generally known as benzoxiquine, which bears US NIH Compound Identifier 6855. European Medicines Agency schedules Benzoxiquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05763MIG. The term BENZOXIQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). BENZOXIQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzoxiquine under HS 29334990 and SITC 51575. As of Q4 2014, BENZOXIQUINE remains the US FDA Preferred Term for this commodity. Benzoxiquine bears US NLM identifiers UMLS ID C0982042 and NCI Concept Code C77027. SMILES: O(C1C2NCCCC2CCC1)C(=O)C1CCCCC1.